ZymoGenetics (ZGEN) Announces Merck Serono to Discontinue Study in Lupus Nephritis in Ongiong Phase II/III Trials

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/17/2026

1. NFLX
2. ISRG
3. USB
4. SLND
5. RGNX
6. RPC
7. AA
8. CFG
9. STT
10. KO

Go back to ZymoGenetics (ZGEN) Announces Merck Serono to Discontinue Study in Lupus Nephritis in Ongiong Phase II/III Trials
ZYMOGENETICS (NASDAQ: ZGEN) Delayed: 12.01 --0 (-0%)
Previous Close $12.01    52 Week High $9.79 
Open $13.09    52 Week Low $3.70 
Day High $12.01    P/E N/A 
Day Low $12.01    EPS $-0.04 
Volume 285,934